Telcagepant
Alternative Names: Caprolactam-azabenzimidazolone - Merck; MK-0974; Telcagepant potassiumLatest Information Update: 05 Nov 2023
At a glance
- Originator Merck & Co
- Class Antimigraines; Piperidines
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Endocrine disorders; Migraine
Most Recent Events
- 29 Jul 2011 Discontinued - Phase-I for Migraine in Belgium (PO)
- 29 Jul 2011 Discontinued - Phase-II/III for Migraine in USA (PO)
- 29 Jul 2011 Discontinued - Phase-III for Migraine in Austria (PO)